Capital Partners Invests in Sterling Medical Devices

General News

Summary

Moonachie, NJ June 23, 2022 Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today an investment in Sterling Medical Devices, a leading provider of design, development and regulatory services to the medical device industry.My team and I are humbled to join the Ampersand family. We look forward to building upon the Companys strong momentum by continuing to add capabilities to its already robust offering.Having successfully completed over 1,500 projects for hundreds of unique customers, Sterling has extensive commercialization experience across the entire medical device development process. Sterling addresses the entire development process including systems, software, electronics, mechanical, quality, compliance, and regulatory affairs. For more information visit https://sterlingmedicaldevices.com/.Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams.

Classifications

industries
HealthTech
applications
Security

AskAI Classifications

Labels
No AI classifications detected

Linked Companies

Vantage MedTech
$10M to $25M